HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

By questioning the FDA's authority to regulate an abortion drug, ... "The FDA approval process is one that is based on extensive, evidence-based, scientific review of efficacy and safety.

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

As abortion-rights activists have pushed to loosen the FDA safety protocols, pro-life advocates have begun pushing in the opposite direction, rightly noting the potentially grave hazards to women ...

Emergency room visits after abortion-drug use were 79 percent more likely to be miscoded as natural miscarriages compared with those following surgical abortions, according to a new study ...

Appeals court embraces abortion-pill limits, sets up Supreme Court review. The Supreme Court has ruled that mifepristone, a key abortion drug, will remain available for now under existing rules ...

A package of mifepristone abortion pills is shown on the left shortly after the drug was approved by the FDA in 2000, while a Viagra pill and packaging are pictured on the right in 1999.

Republican Sen. Josh Hawley’s quest to legitimize a junk science report undermining the safety of a widely used abortion pill was fully realized this week. Food and Drug Administration Commissioner ...

Beyond the implications for abortion, the medication abortion case also has consequences for what kind of authority and discretion the FDA has to determine a drug’s safety and appropriate rules ...